{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:27:00Z","timestamp":1787286420050,"version":"build-2736575974"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Although tea and its bioactive constituents, particularly epigallocatechin gallate (EGCG), demonstrate promising anti-liver fibrotic potential, the global research landscape has yet to be systematically characterized through quantitative visualization, leaving research priorities and clinical translational barriers unclear. This bibliometric analysis aims to delineate the current status, emerging hotspots, and developmental trends in tea-related liver fibrosis research, providing strategic insights for future studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A dual-database search with reciprocal verification was conducted in the Web of Science Core Collection (WoSCC) and Scopus using refined search strategies. Bibliometric analyses and visualizations were performed using R (v4.5.1), VOSviewer (v1.6.19), and CiteSpace (v6.4.R1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Annual publication output in this field has increased steadily. China led in publications (\n                      <jats:italic>n<\/jats:italic>\n                      = 120), with Nutrients and Frontiers in Pharmacology as the leading journals. Tea bioactives exert anti-fibrotic effects through: (1) molecular mechanisms, including inhibition of hepatic stellate cell activation via TGF-\u03b2\/Smad, Nrf2, NF-\u03baB, AMPK, and MAPK pathways; (2) gut-liver axis modulation, such as intestinal microbiota remodeling, bile acid homeostasis restoration, and barrier integrity enhancement; (3) synergistic effects with other natural products; and (4) epidemiological evidence showing that regular tea\/caffeine intake reduces fibrosis progression, cirrhosis, and hepatocellular carcinoma risk. However, EGCG clinical translation is limited by poor solubility, environmental instability, rapid clearance, low oral bioavailability, and dose-dependent hepatotoxicity. Nano-delivery systems and structural modifications have been developed to enhance its bioavailability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study elucidates the therapeutic potential of tea and its bioactive constituents against liver fibrosis, encompassing their pharmacological mechanisms, emerging molecular targets, and bioavailability enhancement strategies. With advances in nanomedicine and pharmaceutical technologies, coupled with rigorously designed multicenter randomized controlled trials, tea-derived bioactives are anticipated to overcome current limitations and establish clinical value in liver fibrosis prevention and adjuvant therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1930581","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:22:40Z","timestamp":1787286160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tea and liver fibrosis: a bibliometric analysis of mechanisms, translational challenges, and emerging trends"],"prefix":"10.3389","volume":"13","author":[{"given":"Fei","family":"Yu","sequence":"first","affiliation":[{"name":"The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha","place":["Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Hunan University of Chinese Medicine, Changsha","place":["Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhu","sequence":"additional","affiliation":[{"name":"The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha","place":["Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Hunan University of Chinese Medicine, Changsha","place":["Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ph18091321","article-title":"Present and future perspectives in the treatment of liver fibrosis.","volume":"18","author":"Cerrito","year":"2025","journal-title":"Pharmaceuticals."},{"key":"B2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives.","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells."},{"key":"B3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation.","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"113006","DOI":"10.1016\/j.intimp.2024.113006","article-title":"Inflammation unleashed: the role of pyroptosis in chronic liver diseases.","volume":"141","author":"Zhu","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jsps.2022.06.021","article-title":"Epigallocatechin gallate ameliorates tetrahydrochloride-induced liver toxicity in rats via inhibition of TGF\u03b2 \/ p-ERK\/p-Smad1\/2 signaling, antioxidant, anti-inflammatory activity.","volume":"30","author":"Mostafa-Hedeab","year":"2022","journal-title":"Saudi Pharm J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"120537","DOI":"10.1016\/j.jep.2025.120537","article-title":"Dark tea ameliorates liver fibrosis via FXR\/TGR5-mediated intestinal permeability and liver sinusoidal capillarization.","volume":"354","author":"Wang","year":"2026","journal-title":"J Ethnopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"116520","DOI":"10.1016\/j.bcp.2024.116520","article-title":"An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis.","volume":"229","author":"Baek","year":"2024","journal-title":"Biochem Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.sjbs.2021.09.023","article-title":"Hepatoprotective effects of methanolic extract of green tea against Thioacetamide-Induced liver injury in Sprague Dawley rats.","volume":"29","author":"Hamad Shareef","year":"2022","journal-title":"Saudi J Biol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/nu14245335","article-title":"Diet and risk of non-alcoholic fatty liver disease, cirrhosis, and liver cancer: a large prospective cohort study in UK biobank.","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients."},{"key":"B10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.14309\/ajg.0000000000000833","article-title":"Obesity, diabetes, coffee, tea, and cannabis use alter risk for alcohol-related cirrhosis in 2 large cohorts of high-risk drinkers.","volume":"116","author":"Whitfield","year":"2021","journal-title":"Am J Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102959","DOI":"10.1016\/j.arr.2025.102959","article-title":"The past, present, and future of adipose tissue browning and aging: a review combined with bibliometrics and bioinformatics of 2527 documents published over the past four decades.","volume":"114","author":"Luo","year":"2026","journal-title":"Ageing Res Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1515\/znc-2021-0321","article-title":"Comparative study of phenolic profile, antioxidant and antimicrobial activities of aqueous extract of white and green tea.","volume":"77","author":"Gabr","year":"2022","journal-title":"Z Naturforsch C J Biosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/antiox8070215","article-title":"Phenolic profiles and antioxidant activities of 30 tea infusions from green, black, oolong, white, yellow and dark teas.","volume":"8","author":"Zhao","year":"2019","journal-title":"Antioxidants."},{"key":"B14","doi-asserted-by":"publisher","first-page":"783886","DOI":"10.3389\/fphar.2021.783886","article-title":"Dihydromyricetin reverses thioacetamide-induced liver fibrosis through inhibiting NF-\u03baB-Mediated inflammation and TGF-\u03b21-Regulated of PI3K\/Akt signaling pathway.","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"154854","DOI":"10.1016\/j.phymed.2023.154854","article-title":"E Se tea extract ameliorates CCl4 induced liver fibrosis via regulating Nrf2\/NF-\u03baB\/TGF-\u03b21\/Smad pathway.","volume":"115","author":"Wang","year":"2023","journal-title":"Phytomedicine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1028418","DOI":"10.3389\/fimmu.2022.1028418","article-title":"Edible plant extracellular vesicles: an emerging tool for bioactives delivery.","volume":"13","author":"Fan","year":"2022","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1009139","DOI":"10.3389\/fnut.2022.1009139","article-title":"Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice.","volume":"9","author":"Gong","year":"2022","journal-title":"Front Nutr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/molecules30030654","article-title":"Epigallocatechin Gallate (EGCG): pharmacological properties, biological activities and therapeutic potential.","volume":"30","author":"Capasso","year":"2025","journal-title":"Molecules."},{"key":"B19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-022-05409-0","article-title":"Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis.","volume":"13","author":"Yin","year":"2022","journal-title":"Cell Death Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11130-011-0211-y","article-title":"Chungtaejeon, a Korean fermented tea, scavenges oxidation and inhibits cytokine induced proliferation and migration of human aortic smooth muscle cells.","volume":"66","author":"Karki","year":"2011","journal-title":"Plant Foods Hum Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00394-024-03504-w","article-title":"EGCG suppressed activation of hepatic stellate cells by regulating the PLCE1\/IP3\/Ca2+ pathway.","volume":"63","author":"Lin","year":"2024","journal-title":"Eur J Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"109506","DOI":"10.1016\/j.jnutbio.2023.109506","article-title":"Regulatory effect of Epigallocatechin-3-O-gallate on circular RNA expression in mouse liver.","volume":"124","author":"Yoshitomi","year":"2024","journal-title":"J Nutr Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"175964","DOI":"10.1016\/j.ejphar.2023.175964","article-title":"Theaflavine inhibits hepatic stellate cell activation by modulating the PKA\/LKB1\/AMPK\/GSK3\u03b2 cascade and subsequently enhancing Nrf2 signaling.","volume":"956","author":"Shu","year":"2023","journal-title":"Eur J Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1021\/acs.jafc.1c01851","article-title":"Efficient preparation of Black Tea Extract (BTE) with the high content of theaflavin mono- and digallates and the protective effects of BTE on CCl4-Induced rat liver and renal injury.","volume":"69","author":"Zhan","year":"2021","journal-title":"J Agric Food Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13020-025-01275-y","article-title":"Integrative multiomics analysis reveals the ameliorative effects of Xiasangju on metabolic dysfunction-associated steatohepatitis.","volume":"21","author":"Xiang","year":"2026","journal-title":"Chin Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"tfae072","DOI":"10.1093\/toxres\/tfae072","article-title":"Lead-induced liver fibrosis and inflammation in mice by the AMPK\/MAPKs\/NF-\u03baB and STAT3\/TGF-\u03b21\/Smad2\/3 pathways: the role of Isochlorogenic acid a.","volume":"13","author":"Guo","year":"2024","journal-title":"Toxicol Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.3748\/wjg.v29.i34.5054","article-title":"Green tea polyphenols alleviate di-(2-ethylhexyl) phthalate-induced liver injury in mice.","volume":"29","author":"Shi","year":"2023","journal-title":"World J Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1147379","DOI":"10.3389\/fimmu.2023.1147379","article-title":"Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis.","volume":"14","author":"He","year":"2023","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"784354","DOI":"10.3389\/fnut.2021.784354","article-title":"Caffeine and EGCG alleviate high-trans fatty acid and high-carbohydrate diet-induced NASH in mice: commonality and specificity.","volume":"8","author":"Xin","year":"2021","journal-title":"Front Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1111\/1750-3841.15929","article-title":"Heukcha, naturally post-fermented green tea extract, ameliorates diet-induced hypercholesterolemia and NAFLD in hamster.","volume":"86","author":"Kang","year":"2021","journal-title":"J Food Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"138715","DOI":"10.1016\/j.foodchem.2024.138715","article-title":"Penthorum chinense Pursh leaf tea debittering mechanisms via green tea manufacturing process and its influence on NAFLD-alleviation activities.","volume":"445","author":"Tian","year":"2024","journal-title":"Food Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"156651","DOI":"10.1016\/j.phymed.2025.156651","article-title":"Preclinical evidence construction for epigallocatechin-3-gallate against non-alcoholic fatty liver disease: a meta-analysis and machine learning study.","volume":"142","author":"Zhang","year":"2025","journal-title":"Phytomedicine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"98146","DOI":"10.4292\/wjgpt.v15.i6.98146","article-title":"Insights of gut-liver axis in hepatic diseases: mechanisms, clinical implications, and therapeutic potentials.","volume":"15","author":"Jeyaraman","year":"2024","journal-title":"World J Gastrointest Pharmacol Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.5009\/gnl20032","article-title":"Leaky gut and gut-liver axis in liver cirrhosis: clinical studies update.","volume":"15","author":"Fukui","year":"2021","journal-title":"Gut Liver."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.21037\/apm-20-2129","article-title":"Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?-a narrative review.","volume":"10","author":"Liu","year":"2021","journal-title":"Ann Palliat Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/ijms22010044","article-title":"Effects of gut metabolites and microbiota in healthy and marginal livers submitted to surgery.","volume":"22","author":"Mic\u00f3-Carnero","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"189563","DOI":"10.1016\/j.bbcan.2026.189563","article-title":"Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: microbial-immune-metabolic network.","volume":"1881","author":"Sun","year":"2026","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s12011-021-02823-x","article-title":"Protective effect of selenium-enriched green tea on carbon tetrachloride-induced liver fibrosis.","volume":"200","author":"Zhang","year":"2022","journal-title":"Biol Trace Elem Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41538-024-00334-2","article-title":"Ampelopsis grossedentata tea alleviating liver fibrosis in BDL-induced mice via gut microbiota and metabolite modulation.","volume":"8","author":"Xi","year":"2024","journal-title":"NPJ Sci Food."},{"key":"B40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jsfa.10049","article-title":"Interactions of tea polyphenols with intestinal microbiota and their implication for anti-obesity.","volume":"100","author":"Zhao","year":"2020","journal-title":"J Sci Food Agric."},{"key":"B41","doi-asserted-by":"publisher","first-page":"156298","DOI":"10.1016\/j.prp.2025.156298","article-title":"EGCG inhibits hepatic stellate cell activity and liver fibrosis by targeting the MDM2\/MUC5AC-mediated TGF-\u03b21\/Smad signaling pathway.","volume":"277","author":"Yang","year":"2026","journal-title":"Pathol Res Pract."},{"key":"B42","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.metop.2024.100322","article-title":"Tea intake and non-alcoholic fatty liver disease risk: a two-sample Mendelian randomization study.","volume":"24","author":"Lu","year":"2024","journal-title":"Metabol Open."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1017\/S0007114524002277","article-title":"Association between dietary tea consumption and non-alcoholic fatty liver disease: a study based on Mendelian randomisation and National Health and Nutrition Examination Survey (2005-2018) association between tea and non-alcoholic fatty liver disease.","volume":"132","author":"Liu","year":"2024","journal-title":"Br J Nutr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"102265","DOI":"10.1016\/j.mtbio.2025.102265","article-title":"Muscle homing peptide modified liposomes loaded with EGCG improved skeletal muscle dysfunction by inhibiting inflammation in aging mice.","volume":"35","author":"Huang","year":"2025","journal-title":"Mater Today Bio."},{"key":"B45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2017.01.009","article-title":"Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery.","volume":"248","author":"Li","year":"2017","journal-title":"J Control Release."},{"key":"B46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/nano9030396","article-title":"Epigallocatechin gallate-gold nanoparticles exhibit superior antitumor activity compared to conventional gold nanoparticles: potential synergistic interactions.","volume":"9","author":"Chavva","year":"2019","journal-title":"Nanomaterials."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.3390\/foods11244074","article-title":"The loading of epigallocatechin gallate on bovine serum albumin and pullulan-based nanoparticles as effective antioxidant.","volume":"11","author":"Li","year":"2022","journal-title":"Foods."},{"key":"B48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.foodchem.2011.07.089","article-title":"Lipophilised epigallocatechin gallate (EGCG) derivatives and their antioxidant potential in food and biological systems.","volume":"131","author":"Zhong","year":"2012","journal-title":"Food Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.3390\/molecules26123485","article-title":"Effect of water hardness on catechin and caffeine content in green tea infusions.","volume":"26","author":"Cabrera","year":"2021","journal-title":"Molecules."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/molecules23092394","article-title":"The effect of ultrasound, oxygen and sunlight on the stability of (-)-Epigallocatechin Gallate.","volume":"23","author":"Zeng","year":"2018","journal-title":"Molecules."},{"key":"B51","doi-asserted-by":"publisher","first-page":"10798","DOI":"10.3390\/ijms262110798","article-title":"Epigallocatechin gallate as a molecular therapeutic in heart failure and cardio-oncology: mechanistic pathways and translational perspectives.","volume":"26","author":"Ajaz","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B52","first-page":"1025","article-title":"Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol Biomark Prevent."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1627949","DOI":"10.3389\/fnut.2025.1627949","article-title":"From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy.","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Nutr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"476180","DOI":"10.1155\/2015\/476180","article-title":"In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes.","volume":"2015","author":"Kucera","year":"2015","journal-title":"Oxid Med Cell Longev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.4254\/wjh.v13.i9.1019","article-title":"Herbal and dietary supplement induced liver injury: highlights from the recent literature.","volume":"13","author":"Woo","year":"2021","journal-title":"World J Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1158\/1940-6207.CAPR-24-0526","article-title":"A Phase I dose-escalation study of polyphenon E in liver cirrhosis: evaluation of safety and effect on Liver \u03b3-OHPdG levels.","volume":"18","author":"He","year":"2025","journal-title":"Cancer Prev Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/19390211.2022.2128501","article-title":"Hepatotoxicity with high-dose green tea extract: effect of Catechol-O-Methyltransferase and uridine 5\u2019-Diphospho-glucuronosyltransferase 1A4 genotypes.","volume":"20","author":"Acosta","year":"2023","journal-title":"J Diet Suppl."},{"key":"B58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.30574\/wjarr.2022.13.1.0019","article-title":"The potency of PLGA-encapsulated epigallocatechin gallate (EGCG) as adjuvant therapy for chronic kidney disease.","volume":"13","author":"Widiatmaja","year":"2022","journal-title":"World J Adv Res Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijpharm.2010.01.012","article-title":"Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease.","volume":"389","author":"Smith","year":"2010","journal-title":"Int J Pharm."},{"key":"B60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nnano.2014.208","article-title":"Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.","volume":"9","author":"Chung","year":"2014","journal-title":"Nat Nanotechnol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1002\/anie.201311136","article-title":"Engineering multifunctional capsules through the assembly of metal-phenolic networks.","volume":"53","author":"Guo","year":"2014","journal-title":"Angew Chem Int Ed Engl."},{"key":"B62","doi-asserted-by":"publisher","first-page":"119616","DOI":"10.1016\/j.biomaterials.2019.119616","article-title":"Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.","volume":"230","author":"Fan","year":"2020","journal-title":"Biomaterials."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/smll.201402870","article-title":"The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.","volume":"11","author":"Duong","year":"2015","journal-title":"Small."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1158\/0008-5472.CAN-08-3978","article-title":"Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.","volume":"69","author":"Siddiqui","year":"2009","journal-title":"Cancer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jconrel.2020.01.042","article-title":"Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis.","volume":"320","author":"Han","year":"2020","journal-title":"J Control Release."},{"key":"B66","doi-asserted-by":"publisher","first-page":"104172","DOI":"10.1016\/j.jff.2020.104172","article-title":"A review on anti-cancer effect of green tea catechins.","volume":"74","author":"Cheng","year":"2020","journal-title":"J Funct Foods."},{"key":"B67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.20473\/jfiki.v6i22019.62-68","article-title":"The effect of vitamin C addition on epigallocatechin gallate (EGCG) stability in green tea solution.","volume":"6","author":"Rahman","year":"2020","journal-title":"J Farmasi Dan Ilmu Kefarmasian Indonesia."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/jn\/134.8.1948","article-title":"Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.","volume":"134","author":"Lambert","year":"2004","journal-title":"J Nutr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/1751-2980.13331","article-title":"Ethnic minority disparities in the epidemiology of metabolic dysfunction-associated steatotic liver disease in a representative area of China.","volume":"25","author":"Ye","year":"2024","journal-title":"J Dig Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cgh.2015.01.030","article-title":"Coffee and caffeine are associated with decreased risk of advanced hepatic fibrosis among patients with hepatitis C.","volume":"13","author":"Khalaf","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jhep.2017.03.013","article-title":"Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: the Rotterdam study.","volume":"67","author":"Alferink","year":"2017","journal-title":"J Hepatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13578-024-01321-6","article-title":"Dietary contributions in the genetic variation of liver fibrosis: a genome-wide association study of fibrosis-4 index in the liver fibrosis development.","volume":"14","author":"Palupi","year":"2024","journal-title":"Cell Biosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3892\/ijmm.2013.1503","article-title":"Green tea with high-density catechins improves liver function and fat infiltration in Non-Alcoholic Fatty Liver Disease (NAFLD) patients: a double-blind placebo-controlled study.","volume":"32","author":"Sakata","year":"2013","journal-title":"Int J Mol Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/jgh.16554","article-title":"Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.","volume":"39","author":"Wu","year":"2024","journal-title":"J Gastroenterol Hepatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jhn.12698","article-title":"Dietary total antioxidant capacity is positively associated with muscular strength in cirrhotic outpatients: a cross-sectional study.","volume":"33","author":"de Freitas Lima","year":"2020","journal-title":"J Hum Nutr Diet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/nu10060705","article-title":"Impact of alcohol and coffee intake on the risk of advanced liver fibrosis: a longitudinal analysis in HIV-HCV coinfected patients (ANRS HEPAVIH CO-13 Cohort).","volume":"10","author":"Yaya","year":"2018","journal-title":"Nutrients."},{"key":"B77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/nu9010056","article-title":"Coffee intake is associated with a lower liver stiffness in patients with non-alcoholic fatty liver disease, Hepatitis C, and Hepatitis B.","volume":"9","author":"Hodge","year":"2017","journal-title":"Nutrients."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1111\/liv.14638","article-title":"Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease.","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int."},{"key":"B79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18999\/nagjms.84.1.19","article-title":"Progression of liver fibrosis and associated factors among chronic hepatitis B patients at a general hospital in Northern Vietnam.","volume":"84","author":"Luu","year":"2022","journal-title":"Nagoya J Med Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.cgh.2021.09.042","article-title":"Coffee consumption is associated with lower liver stiffness: a nationally representative study.","volume":"20","author":"Niezen","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.gastro.2014.10.005","article-title":"Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.","volume":"148","author":"Setiawan","year":"2015","journal-title":"Gastroenterology."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1930581\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:22:42Z","timestamp":1787286162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1930581\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":81,"alternative-id":["10.3389\/fnut.2026.1930581"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1930581","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"article-number":"1930581"}}